| Class 3 Device Recall Abbott RealTime CT/NG Assay | |
Date Initiated by Firm | December 20, 2010 |
Date Posted | February 23, 2011 |
Recall Status1 |
Terminated 3 on November 19, 2012 |
Recall Number | Z-1397-2011 |
Recall Event ID |
57431 |
510(K)Number | K092704 |
Product Classification |
Dna-reagents, chlamydia - Product Code LSK
|
Product | Abbott RealTime CT/NG Assay, List 8L07, in vitro diagnostic; Abbott Molecular Inc., Des Plaines, IL 60018 USA
The Abbott RealTime CT/NG assay is an in vitro polymerase chain reaction (PCR) assay for the direct, qualitative detection of the plasmid DNA for C. trachomatis and the genomic DNA of N. gonorrhoeae in female endocervical or vaginal swab specimens, male urethral swab specimens, or in male and female urine specimens. |
Code Information |
All in date lots |
Recalling Firm/ Manufacturer |
Abbott Molecular 1300 E Touhy Ave Des Plaines IL 60018-3315
|
For Additional Information Contact | 224-361-7133 |
Manufacturer Reason for Recall | Internal testing identified the potential of under filled and over filled enzyme reagent vials which may result in obtaining less than the total number of tests per kit as described on the package insert. |
FDA Determined Cause 2 | Other |
Action | Abbott Molecular sent a Field Advisory Notice letter to all RealTime HIV-1, CT/NG and HBV assay customers on December 20, 2010, informing them that internal testing identified the potential of under filled and over filled enzyme vials which may result in obtaining less than the total number of tests per kit as described in the package insert. The customers were told that specimens that meet acceptance criteria, per the product labeling are not affected by the situation and are considered valid results, and that the issue has no impact on results for those runs that generate valid results. Any questions were directed to Abbott Technical Support at 1-800-553-7042, Option 2. |
Distribution | Nationwide Distribution |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = LSK
|
|
|
|